Drug intelligence / Profile preview

Liposic EDO

Development stage
Unknown
Lead developer
Dr. Gerhard Mann
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules
Administration
Ophthalmic
01

Overview

Liposic EDO is a highly viscous ophthalmic gel formulated for the symptomatic treatment of dry eye syndrome. Its primary active ingredient is carbomer, which acts as a tear substitute and lubricant by forming a protective and moisturizing layer over the ocular surface. This gel mimics natural tears by stabilizing all three layers of the tear film—lipid, aqueous, and mucin—providing long-lasting relief from irritation, burning, or tiredness associated with dry eyes. The formulation also includes cetrimide (as preservative), sorbitol, medium-chain triglycerides for enhanced viscosity and comfort, sodium hydroxide for pH adjustment to match natural tears (pH 7.4), and purified water[1][2][3]. It is particularly suitable for moderate to severe dry eye symptoms and can be used multiple times daily but should not be applied while wearing contact lenses.

Brand names
Liposic EDOLiposicLiposic Eye GelLipolac (Spain)Lipovisc (Italy)
Other names
carbomer-based lipid-containing artificial tear formulationcarbomer-based lipid-containing gelCBLATCBLC gel

Beyond the preview

Go deeper on Liposic EDO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liposic EDO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call